#blood test
Related Stories (2)
FDA approves Freenome's blood test for colorectal cancer screening - Reuters
FDA approves Freenome's blood test for colorectal cancer screening Reuters
July 27, 2026Multi-cancer blood test missed key goal in NHS trial
The company behind the test said there were positive signs that some of the most aggressive cancers could be prevented.
February 21, 2026Related Pages (2)
Untitled
window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa
news.google.com•July 27, 2026
Multi-cancer blood test missed key goal in NHS trial
A blood test which looks for multiple types of cancer has failed to achieve its key objective in a major NHS trial, the company has announced. The Galleri blood test is being trialled on 142,000 NHS
bbc.com•February 24, 2026